CHEMBIO DIAGNOSTICS, INC. Accounts Receivable
CHEMBIO DIAGNOSTICS, INC. had Accounts Receivable of $6.54 million as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-03-29
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $6.54M.
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $5.25M.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $4.26M.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $9.88M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2022-12-31 | $6.54M 10-K · filed 2023-03-29 | |
| 2022-09-30 | $5.25M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.26M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $9.88M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $11.44M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $6.78M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $2.98M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $2.41M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $3.38M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $3.52M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.61M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.88M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $3.66M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $5.38M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $7.73M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $7.72M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $7.37M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $7.79M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $6.89M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $3.81M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.09M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $5.77M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $4.67M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $5.68M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $3.38M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $4.21M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $4.58M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $4.90M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $2.42M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $9.51M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $8.87M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $8.26M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $8.34M 10-K · filed 2016-03-08 | |
| 2014-09-30 | $8.32M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $5.42M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $3.37M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $4.59M 10-K · filed 2015-03-05 | |
| 2013-09-30 | $5.51M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $3.89M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $5.28M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $4.82M 10-K · filed 2014-03-06 | |
| 2012-09-30 | $2.57M 10-Q/A · filed 2012-11-13 | |
| 2012-06-30 | $2.22M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $3.62M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $3.00M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $2.66M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $1.64B 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $3.95M 10-K · filed 2012-03-08 | $3.95B 10-Q · filed 2011-08-04 |